Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
antipsychotic, assimilated, bankruptcy, Beach, biosimilar, blockade, clarify, CMO, Coast, cough, DSPPP, everyday, exceptionally, favourable, fourteen, geopolitical, Gi, Hwy, IFRIC, inflation, interchangeability, interchangeable, IRA, IRC, Laguna, lifelong, loan, mice, moment, monetize, NDD, neurodevelopmental, neuropsychiatric, Ordinance, outpace, pat, penalize, quickly, realigned, reclassed, repaid, repaying, repriced, retention, secound, shelf, shortfall, speculative, SR, stroke, SUD, unfavourable, unvested, xanomeline
Removed:
accommodate, adapted, analyze, anchored, anticholinergic, awkward, Azerbaijan, botulinum, Bruce, budgeted, CAM, CDK, cervical, clostridium, comparison, complication, concurrently, confirmatory, consisting, consolidating, creation, curb, diary, Disord, distinguished, emergency, exclude, excluded, exploratory, familial, focal, Hunt, idiopathic, inclusion, infirm, intervention, invented, investigate, investigator, involuntarily, irregular, Jersey, Kazakhstan, Kovner, Kyrgyzstan, Lathi, left, limb, magnetic, mandated, marginal, Medytox, Moldova, Mov, norm, OLS, overlay, OVN, parallel, pharmacologic, POC, practical, precise, prediction, preemptive, Presently, Princeton, prone, Psychosocial, qualifying, rater, reassessed, reflective, refractory, removal, renew, repeal, repetitive, replace, Roche, Ronald, segmental, spasm, spreading, Standardized, structured, subjective, subset, Tajikistan, tetrabenazine, topline, toxin, trained, transcranial, travel, Trump, Turkmenistan, twisting, undergone, usage, variability, Vijay, visit, Wilmington
Filing tables
Filing exhibits
ADXN similar filings
Filing view
External links
Exhibit 15.1
Consent of Independent Registered Public Accounting Firm
Addex Therapeutics Ltd
Geneva, Switzerland
We hereby consent to the incorporation by reference in the Registration Statements on Form F-3 (No. 333-255089) and S-8 (No. 333-255124) of our report dated March 30, 2023, relating to the consolidated financial statements of Addex Therapeutics Ltd, which is included in this Form 20-F. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
Zurich, Switzerland, March 30, 2023
BDO AG
/s/ Christoph Tschumi | /s/ Nigel Le Masurier |